Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.

Am Heart J

Department of Surgery, Erasmus MC, Rotterdam, The Netherlands.

Published: December 2004

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ahj.2004.05.046	DOI Listing

Publication Analysis

fluvastatin bisoprolol

bisoprolol reduction

reduction perioperative

perioperative cardiac

cardiac mortality

mortality morbidity

morbidity high-risk

high-risk patients

patients undergoing

undergoing non-cardiac

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!